Protective MMR Vaccine - Single Dose Vial: Optimal Protection Against Measles, Mumps, and Rubella

SKU: S0001383
Procurenet
Short description

Ensure optimal immunization against measles, mumps, and rubella with the Protective MMR Vaccine – Single Dose Vial. This freeze-dried powder serves as an absolute guard against these viruses. Key specifications include:

  • Dose Content: Each vaccination comprises CCID50 of each virus, for maximum potency.
  • Production: Formulated in human diploid cells or chicken embryo fibroblasts.
  • Administration: Single 0.5 ml dose injection in the upper arm using sterile apparatus.
  • Storage: Use within six hours of reconstitution and store between 2°C and 8°C, safe from sunlight.
  • Transport: For safe transport, freeze at -20°C or refrigerate between 2°C and 8°C.

Immunization schedules may vary based on measles incidence in different regions.

Quantity :
  • Procurenet Team Tshim Sha Tsui
    Hong Kong Hong Kong 3 years
Description

Protective MMR Vaccine - Single Dose Vial: Optimal Protection Against Measles, Mumps, and Rubella

A world-class solution designed to support comprehensive immunization efforts, the Protective MMR Vaccine - Single Dose Vial offers advanced protection against three infectious diseases: measles, mumps, and rubella. This formula ensures top-tier potency, safety, and efficacy to help defeat these troublesome illnesses

Key Features and Benefits:

  • Proactively fortifies against measles, mumps, and rubella
  • Maintains a potent minimum strength of 1000 CCID50 of each virus
  • Utilizes WHO-prequalified strains such as Edmonston Zagreb, Schwarz, Biken Cam 70, L-Zagreb, Jeryl Lynn, Urabe, and RA-27/3
  • Possesses slight antibiotic residue used in the production process
  • Color ranges between white and yellowish-white for effortless recognition

How to Properly Administer:

  • Administer 0.5 ml of vaccine either subcutaneously or intramuscularly, ideally in the upper arm
  • Avoidance of sunlight exposure preserves the vaccine's strength and potency
  • Use vaccine within 6 hours upon reconstitution, discarding the opened vial after the session
  • Utilize the provided diluent specifically designed for this vaccine

Vaccination Timeline:

In high-risk areas, administer the MMR vaccine at 9 months. In zones with lower measles prevalence, vaccination may occur around 12-15 months, with a second dose administered alongside other vaccines and vitamin A supplements when needed

Transportation and Storage Guidelines:

Keep the MMR Vaccine Frozen at -20u2022C or refrigerate between 2u2022C and 8u2022C until use. Ensuring careful transport, vials and diluents must be stored together and protected from sunlight to maintain efficacy

All categories
Filters